63 related articles for article (PubMed ID: 1362620)
1. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
Bergenfeldt M; Axelsson L; Ohlsson K
Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
Weldon S; McNally P; McElvaney NG; Elborn JS; McAuley DF; Wartelle J; Belaaouaj A; Levine RL; Taggart CC
J Immunol; 2009 Dec; 183(12):8148-56. PubMed ID: 20007580
[TBL] [Abstract][Full Text] [Related]
3. Targeted Library of Phosphonic-Type Inhibitors of Human Neutrophil Elastase.
Torzyk-Jurowska K; Ciekot J; Winiarski L
Molecules; 2024 Mar; 29(5):. PubMed ID: 38474630
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides.
Li Y; Yang Q; Dou D; Alliston KR; Groutas WC
Bioorg Med Chem; 2008 Jan; 16(2):692-8. PubMed ID: 17976994
[TBL] [Abstract][Full Text] [Related]
5. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis.
Song Xy; Zeng L; Jin W; Thompson J; Mizel DE; Lei K; Billinghurst RC; Poole AR; Wahl SM
J Exp Med; 1999 Aug; 190(4):535-42. PubMed ID: 10449524
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil elastase and endogenous inhibitors in Behçet's disease saliva.
Novak T; Fortune F; Bergmeier L; Khan I; Hagi-Pavli E
Clin Exp Immunol; 2020 Oct; 202(1):93-105. PubMed ID: 32580239
[TBL] [Abstract][Full Text] [Related]
7. Structure basis 1/2SLPI and porcine pancreas trypsin interaction.
Fukushima K; Kamimura T; Takimoto-Kamimura M
J Synchrotron Radiat; 2013 Nov; 20(Pt 6):943-7. PubMed ID: 24121345
[TBL] [Abstract][Full Text] [Related]
8. Human neutrophil elastase inhibitors: Classification, biological-synthetic sources and their relevance in related diseases.
Ocampo-Gallego JS; Pedroza-Escobar D; Caicedo-Ortega AR; Berumen-Murra MT; Novelo-Aguirre AL; de Sotelo-León RD; Delgadillo-Guzmán D
Fundam Clin Pharmacol; 2024 Feb; 38(1):13-32. PubMed ID: 37609718
[TBL] [Abstract][Full Text] [Related]
9. Measuring the Concentration of Active Alpha-1 Antitrypsin in Serum.
Bristow CL
Methods Mol Biol; 2024; 2750():71-77. PubMed ID: 38108968
[TBL] [Abstract][Full Text] [Related]
10. Complete non-proline backbone resonance assignments of the S. aureus neutrophil serine protease inhibitor, EapH1.
Mishra N; Pal I; Herrera AI; Dubey A; Arthanari H; Geisbrecht BV; Prakash O
Biomol NMR Assign; 2023 Jun; 17(1):129-134. PubMed ID: 37160842
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil elastase inhibitors.
Groutas WC; Dou D; Alliston KR
Expert Opin Ther Pat; 2011 Mar; 21(3):339-54. PubMed ID: 21235378
[TBL] [Abstract][Full Text] [Related]
12. Investigating Polypharmacology through Targeting Known Human Neutrophil Elastase Inhibitors to Proteinase 3.
Gartan P; Khorsand F; Mizar P; Vahokovski JI; Cervantes LF; Haug BE; Brenk R; Brooks CL; Reuter N
J Chem Inf Model; 2024 Feb; 64(3):621-626. PubMed ID: 38276895
[TBL] [Abstract][Full Text] [Related]
13. Alpha(1)-proteinase inhibitor (human).
P T; 2010 Mar; 35(3 Section 2):2-6. PubMed ID: 20463868
[No Abstract] [Full Text] [Related]
14. α-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease.
Sinden NJ; Baker MJ; Smith DJ; Kreft JU; Dafforn TR; Stockley RA
Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L179-90. PubMed ID: 25416382
[TBL] [Abstract][Full Text] [Related]
15. Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid.
Laugisch O; Schacht M; Guentsch A; Kantyka T; Sroka A; Stennicke HR; Pfister W; Sculean A; Potempa J; Eick S
Mol Oral Microbiol; 2012 Feb; 27(1):45-56. PubMed ID: 22230465
[TBL] [Abstract][Full Text] [Related]
16. Investigation of midtrimester amniotic fluid factors as potential predictors of term and preterm deliveries.
Malamitsi-Puchner A; Vrachnis N; Samoli E; Baka S; Alexandrakis G; Puchner KP; Iliodromiti Z; Hassiakos D
Mediators Inflamm; 2006; 2006(4):94381. PubMed ID: 17047297
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis.
Ohlsson S; Falk R; Yang JJ; Ohlsson K; Segelmark M; Wieslander J
Clin Exp Immunol; 2003 Jan; 131(1):190-6. PubMed ID: 12519404
[TBL] [Abstract][Full Text] [Related]
18. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.
Ohlsson S; Ljungkrantz I; Ohlsson K; Segelmark M; Wieslander J
Mediators Inflamm; 2001 Dec; 10(6):347-50. PubMed ID: 11817677
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).
Fantuzzi G; Dinarello CA
J Clin Immunol; 1999 Jan; 19(1):1-11. PubMed ID: 10080100
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
Berling R; Borgström A; Ohlsson K
Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
